Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Daily News

Money Talk: Cardiologists Must Weigh Costs as Transcatheter Therapies Ascend

Caitlin E. Cox

August 11, 2025

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Daily News

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Yael L. Maxwell

May 01, 2024

News Conference News TCT 2023

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Yael L. Maxwell

October 26, 2023

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

Excluded from Pivotal Trials, Low-risk Complex Patients Warrant Caution

News Daily News

Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution

L.A. McKeown

January 22, 2021

News Daily News

Tricuspid Interventions OK With Pacemakers, ICDs: TriValve Registry

Todd Neale

January 17, 2020

News Daily News

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Michael O'Riordan

August 06, 2018

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

News Daily News

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

Caitlin E. Cox

February 07, 2017

Advertisement

Money Talk: Cardiologists Must Weigh Costs as Transcatheter Therapies Ascend

December 2024 Dispatch for the CV Team

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution

Tricuspid Interventions OK With Pacemakers, ICDs: TriValve Registry

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content